Quest Diagnostics

Quest Diagnostics Inc (NYSE:DGX) Shares Sold by Truvestments Capital LLC | 10/11/2019

Truvestments Capital LLC lessened its stake in Quest Diagnostics Inc (NYSE:DGX) by 3.7% in the 3rd its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,470 shares of the medical research company’s stock after selling 251 shares during the period. Truvestments Capital LLC’s holdings in Quest Diagnostics were worth $693,000 as of its most recent filing with the Securities and Exchange …

Quest Diagnostics Inc (NYSE:DGX) Stake Cut by Amundi Pioneer Asset Management Inc. | 10/11/2019

Amundi Pioneer Asset Management Inc. decreased its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 1.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,347,265 shares of the medical research company’s stock after selling 14,939 shares during the period. Quest Diagnostics accounts for 0.8% of Amundi Pioneer Asset Management Inc.’s holdings, making the stock its …

Follow Quest Diagnostics:    

Crossmark Global Holdings Inc. Sells 2,819 Shares of Quest Diagnostics Inc (NYSE:DGX) | 10/10/2019

Crossmark Global Holdings Inc. trimmed its stake in Quest Diagnostics Inc (NYSE:DGX) by 2.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 121,764 shares of the medical research company’s stock after selling 2,819 shares during the period. Crossmark Global Holdings Inc.’s holdings in Quest Diagnostics were worth $13,032,000 at the end of the most recent reporting …

Brokerages Anticipate Quest Diagnostics Inc (NYSE:DGX) Will Post Quarterly Sales of $1.94 Billion | 10/10/2019

Analysts predict that Quest Diagnostics Inc (NYSE:DGX) will announce $1.94 billion in sales for the current quarter, Zacks reports. Seven analysts have made estimates for Quest Diagnostics’ earnings. The lowest sales estimate is $1.94 billion and the highest is $1.95 billion. Quest Diagnostics reported sales of $1.89 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 2.6%. The firm is scheduled …

Brokerages Anticipate Quest Diagnostics Inc (NYSE:DGX) Will Announce Quarterly Sales of $1.94 Billion | 10/10/2019

Analysts expect Quest Diagnostics Inc (NYSE:DGX) to post $1.94 billion in sales for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Quest Diagnostics’ earnings, with estimates ranging from $1.94 billion to $1.95 billion. Quest Diagnostics reported sales of $1.89 billion in the same quarter last year, which would suggest a positive year over year growth rate of 2.6%. The business is scheduled to report its …

Global Bone Densitometers & Bone Turnover Marker Tests Markets to 2023 - Technologies, Top-selling Devices, Leading Manufacturers | PR Newswire | 10/9/2019

… turnover marker tests, leading competitors include Roche and Alere. Companies Mentioned Alere/Abbott Beckman Coulter /Danaher BeamMed CompuMed Furuno Electric Company GE Healthcare/General Electric Company Hologic Swissray Immunodiagnostic Systems Orion Diagnostica/Orion Group Quest Diagnostics Quidel Roche Diagnostics/F. Hoffmann-La Roche Key Topics Covered Executive Summary Market analysis Selected market drivers and limiters Market leaders Methodology Exhibit ES-1: Bone densitometry systems and bone turnover marker tests, combined …

Maine Has Some Of The Highest Rates In The Nation Of Workers Who Test Positive For Drugs | 10/9/2019

Maine has some of the highest rates in the nation of workers who test positive for drugs. According to recent numbers released by the testing service Quest Diagnostics , about 6 percent of workers tested in Maine had positive results last year. That ranks only below Oregon, but is similar to other New England states. Amanda O’Leary, with the Maine Department of Labor, says the numbers are comparable to what her …

New York Giants: Asafo-Adjei is a True Warrior | 10/9/2019

written by Brittany Sirabella October 9, 2019 May 4, 2019; East Rutherford, NJ, USA; New York Giants offensive tackle George Asafo-Adjei (78) speaks to media during rookie minicamp at Quest Diagnostics Training Center. Mandatory Credit: Sarah Stier-USA TODAY Sports The New York Giants offensive line has come under much scrutiny and criticism over the past few seasons. While there could be improvements, what could help the New York …

Adult-Use Legalization Could Hurt Michigan Workers At Drug-Testing Time | Benzinga | 10/9/2019

… say their pre-employment drug screenings that include cannabis will not change. The state’s residents already are failing pre-employment drug screening tests at a rate higher than elsewhere in the nation. According to Quest Diagnostics data, the numbers of people who didn’t pass pre-employment drug screenings and likely lost potential job opportunities has increased by 31% from 2014 to 2018, and jumped more than 20% between 2017 and …

Quest Diagnostics Inc (NYSE:DGX) Expected to Announce Quarterly Sales of $1.94 Billion | 10/8/2019

Wall Street brokerages expect that Quest Diagnostics Inc (NYSE:DGX) will post $1.94 billion in sales for the current quarter, according to Zacks Investment Research . Seven analysts have made estimates for Quest Diagnostics’ earnings. The highest sales estimate is $1.95 billion and the lowest is $1.94 billion. Quest Diagnostics posted sales of $1.89 billion during the same quarter last year, which would indicate a positive year over year growth rate …

Zacks: Analysts Anticipate Quest Diagnostics Inc (NYSE:DGX) to Post $1.72 EPS | 10/8/2019

Equities research analysts expect that Quest Diagnostics Inc (NYSE:DGX) will post earnings of $1.72 per share for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Quest Diagnostics’ earnings. The highest EPS estimate is $1.79 and the lowest is $1.65. Quest Diagnostics posted earnings per share of $1.68 in the same quarter last year, which suggests a positive year-over-year growth rate of 2.4 …

Quest Diagnostics Inc (NYSE:DGX) Expected to Post Earnings of $1.72 Per Share | 10/8/2019

Wall Street brokerages expect that Quest Diagnostics Inc (NYSE:DGX) will post earnings of $1.72 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Quest Diagnostics’ earnings. The lowest EPS estimate is $1.65 and the highest is $1.79. Quest Diagnostics reported earnings per share of $1.68 in the same quarter last year, which would suggest a positive year-over-year growth rate …

Quest Diagnostics Inc (NYSE:DGX) Expected to Post Quarterly Sales of $1.94 Billion | 10/8/2019

Equities research analysts forecast that Quest Diagnostics Inc (NYSE:DGX) will announce sales of $1.94 billion for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Quest Diagnostics’ earnings, with the highest sales estimate coming in at $1.95 billion and the lowest estimate coming in at $1.94 billion. Quest Diagnostics reported sales of $1.89 billion during the same quarter last year, which would indicate a positive …

Contravisory Investment Management Inc. Purchases New Stake in Quest Diagnostics Inc (NYSE:DGX) | 10/8/2019

Contravisory Investment Management Inc. purchased a new stake in shares of Quest Diagnostics Inc (NYSE:DGX) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,010 shares of the medical research company’s stock, valued at approximately $322,000. A number of other large investors have also recently bought and sold shares of the stock. Pearl River Capital LLC bought a …

State of Alaska Department of Revenue Boosts Holdings in Quest Diagnostics Inc (NYSE:DGX) - Ticker Report | 10/7/2019

State of Alaska Department of Revenue lifted its stake in Quest Diagnostics Inc (NYSE:DGX) by 10.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 77,043 shares of the medical research company’s stock after buying an additional 7,532 shares during the quarter. State of Alaska Department of Revenue’s holdings in Quest Diagnostics were worth $8,245,000 at the end of the most recent quarter. Several other large investors also recently …

Zacks: Brokerages Anticipate Quest Diagnostics Inc (NYSE:DGX) Will Post Quarterly Sales of $1.94 Billion - TheOlympiaReport | 10/7/2019

Wall Street brokerages forecast that Quest Diagnostics Inc (NYSE:DGX) will announce sales of $1.94 billion for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Quest Diagnostics’ earnings. The highest sales estimate is $1.95 billion and the lowest is $1.94 billion. Quest Diagnostics reported sales of $1.89 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 2.6 …

Is There a Better Way to Drug Test? | 10/6/2019

… the best solution for your fleet. Drug-testing labs are getting more sophisticated about catching cheaters, but at the same time, cheaters are getting smarter about how they try to game the system. Photo: Quest Diagnostics Cheating the tests In that 2008 study, GAO investigators posed as commercial truck drivers needing DOT drug tests. At 10 of 24 testing sites, testers did not ask them to empty their pants pockets …

Marshall Wace LLP Has $27.64 Million Stake in Quest Diagnostics Inc (NYSE:DGX) | 10/6/2019

Marshall Wace LLP Has $27.64 Million Stake in Quest Diagnostics Inc (NYSE:DGX) Posted by Cindy Kellogue on Oct 6th, 2019 Marshall Wace LLP grew its position in Quest Diagnostics Inc (NYSE:DGX) by 10.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 271,530 shares of the medical research company’s stock after acquiring an additional 25,916 shares during …

Webster Bank N. A. Makes New Investment in Quest Diagnostics Inc (NYSE:DGX) - Dakota Financial News | 10/6/2019

Webster Bank N. A. purchased a new stake in Quest Diagnostics Inc (NYSE:DGX) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 500 shares of the medical research company’s stock, valued at approximately $54,000. Several other hedge funds and other institutional investors have also bought and sold shares of DGX. Thoroughbred Financial Services LLC boosted its holdings in shares of Quest Diagnostics …

Webster Bank N. A. Takes $54,000 Position in Quest Diagnostics Inc (NYSE:DGX) | 10/5/2019

Webster Bank N. A. Takes $54,000 Position in Quest Diagnostics Inc (NYSE:DGX) Posted by Nadine Saad on Oct 5th, 2019 Tweet Webster Bank N. A. purchased a new stake in Quest Diagnostics Inc (NYSE:DGX) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 500 shares of the medical research company’s stock, valued at approximately $54,000. Several …

Medical Research

Quest Diagnostics Inc (NYSE:DGX) Shares Sold by Truvestments Capital LLC | 10/11/2019

Truvestments Capital LLC lessened its stake in Quest Diagnostics Inc (NYSE:DGX) by 3.7% in the 3rd its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,470 shares of the medical research company’s stock after selling 251 shares during the period. Truvestments Capital LLC’s holdings in Quest Diagnostics were worth $693,000 as of its most recent filing with the Securities and Exchange …

AMCA

Sonoma Valley Hospital Website, Email Addresses Hijacked | HealthIT Security | 8/22/2019

… Hackers hijacked the California provider’s coveted three-letter domain name, forcing Sonoma Hospital to change its URL; ransomware, a new AMCA breach victim, and an email hack complete this week’s breach roundup. By August 22 … billing collections vendor began notifying clients in May, which includes Quest Diagnostics, LabCorp , BioReference , Inform Diagnostics, and a host of others. AMCA notified IRL of the breach on June 3 and confirmed IRL patient data …

July-reported healthcare breaches exposed 22 million people’s data | Modern Healthcare | 8/9/2019

Quest Diagnostics in June said a data breach resulting from an unauthorized user accessing the vendor’s web payment system between August 2018 and March 2019 had affected millions of their patients, but that AMCA had not yet provided them with information on which patients’ data was exposed. After further investigation, Optum360, one of Quest’s revenue-cycle contractors, on July 1 filed a formal report of the data breach with the …

Medicare

United States Medical Billing Outsourcing Market: Size, Share & Trends Analysis Report (2019-2026) - ResearchAndMarkets.com | Business Wire | 9/4/2019

… among young generation are resulting in widened base of patients in the country. Furthermore, growing burden on revenues & profits, declining Medicare payments, and mounting billing volumes are leading to need to decrease in-house processing … Information Solutions, Inc.; EClinicalWorks; GE Healthcare; Genpact; McKesson Corporation; Kareo; Quest Diagnostics; and The SSI Group. Further key findings from the study suggest: Advantages associated with outsourcing of medical billing services include improvement in billing …

United States Medical Billing Outsourcing Market Nears $8 Billion by 2026 - Growing Focus on Increasing Business Profitability & Revenue Generation | Globe Newswire | 9/4/2019

… diseases among young generation are resulting in widened base of patients in the country.Furthermore, growing burden on revenues & profits, declining Medicare payments, and mounting billing volumes are leading to need to decrease in-house processing … Information Solutions, Inc.; EClinicalWorks; GE Healthcare; Genpact; McKesson Corporation; Kareo; Quest Diagnostics; and The SSI Group. Further key findings from the study suggest: Advantages associated with outsourcing of medical billing services include improvement in billing …

AMA

Aptar Pharma of Crystal Lake buys two companies to boost its pharmaceutical packaging business. | Crain’s Chicago Business | 6/16/2019

June 12, 2019 05:15 AM Packaging firm beefs up pharma business • AMA president lists priorities • AbbVie skin drug shows promise Aptar Pharma of Crystal Lake buys two companies to boost its pharmaceutical packaging business. Print … collection services to healthcare organizations, Modern Healthcare reports . LabCorp and Quest Diagnostics last week said that the data breach affected nearly 8 million and 12 million of their patients, respectively. OAK STREET OPENING MORE MICHIGAN …

Mount Sinai launches AI center backed by Blackstone’s James | Crain’s New York Business | 6/11/2019

… a center focused on advancing health care through the research, development and implementation of artificial intelligence technologies. The Hamilton and Amabel James Center for Artificial Intelligence and Human Health is supported by a donation from … Bob Menendez and Cory Booker requested information from LabCorp and Quest Diagnostics after a breach at a third-party vendor, American Medical Collection Agency, compromised the protected health information of nearly 20 million patients. “Consumers …

Clinical Diagnostics

Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays Report 2019: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation - ResearchAndMarkets.com | Business Wire | 9/30/2019

Clinical Diagnostics Proteome Sciences Quest Diagnostics Quidel For more information about this report visit https://www.researchandmarkets.com/r/1fluai Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …

$69.2 Bn In-Vitro Diagnostic Tests Markets, 2024 | PR Newswire | 9/25/2019

Clinical Diagnostics (Ortho) Oxford Nanopore Technologies Ltd Pacific Biosciences of California , Inc. (PacBio) PerkinElmer, Inc. (PE) Philips ( Royal Philips ) PositiveID Corporation PTS Diagnostics QIAGEN N.V. Q-linea AB QuanDx Inc QuantuMDx Group, Ltd. Quest Diagnostics Quidel Corporation Radiometer A/S / Danaher RainDance Technologies, Inc. Randox Laboratories Ltd. Rheonix, Inc. Roche Diagnostics Rubicon Genomics, Inc. Samsung Healthcare Scienion AG Seegene, Inc. Sekisui Diagnostics LLC Shimadzu Scientific Instruments Siemens Healthineers (Siemens) Snibe …

Precision Medicine

Visiongain Report Offers Transformative Insights on the $8.6bn Inflammatory Bowel Diseases (IBD) Drug Market | PR Newswire | 8/30/2019

… Oncobiologics Ortho Biotech Osiris Therapeutics Otsuka Ovamed Palau Pharma Par Pharmaceuticals Pendopharm Perrigo Pfenex Pfizer Pharmascience Pluristem Therapeutics Qu Biologics Quest Diagnostics Ranbaxy Laboratories Receptos RedHill Biopharma Reliance Life Sciences Roche Salix Pharmaceuticals Sandoz Sanofi … [email protected] Related reports: Generic Drugs Market Forecast 2019-2029 Global Precision Medicine Market Forecast 2019-2029 Global Antibacterial Drugs Market 2019-2029 Global Human Microbiome Therapeutics Market Forecast 2019-2029 Global Biosimilars and Follow-On Biologics Market 2019-2029 …

Global NGS-Based Monitoring and Diagnostic Test Market to Reach $18.03 Billion by 2028 | Markets Insider | Business Insider | 8/28/2019

… depending on the genetic profile of an individual. The completion of the project, subsequently, created platform for the development of precision medicines. One of the revolutionary breakthroughs, which NGS has resulted in, is precision medicine … Laboratory Corporation of America Holdings, Myriad Genetics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Inc., and Thermo Fisher Scientific Inc. Key Questions Answered in the Report What are the major market drivers, challenges, and …

Clinical Genomics

Global Colorectal Cancer Market Review & Outlook (2017-2026) - ResearchAndMarkets.com | Business & Finance | manchestertimes.com | Business Wire | 9/16/2019

Clinical Genomics, EDP Biotech, Epigenomics, Hoffmann-La Roche, Novigenix, Quest Diagnostics, Sanofi, Siemens Healthineers and VolitionRX. What the report offers: Market share assessments for the regional and country level segments Strategic recommendations for the new entrants Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic analysis: Drivers and …

Global NGS-Based Monitoring and Diagnostic Test Market to Reach $18.03 Billion by 2028 | PR Newswire | 8/28/2019

… AG, F. Hoffmann-La Roche Ltd, GenePath DX, illumine Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Inc., and Thermo Fisher Scientific Inc. Key Questions Answered in … the forecast period 2019-2028? Related Reports: Global NGS Informatics and Clinical Genomics Market, 2018 to 2028 Global Next Generation Sequencing (NGS) Market - Analysis and Forecast, 2017-2024 About BIS Research: BIS Research is a global B2B …

Revenue Cycle Management

Revenue Cycle Management Market Growth, Trends, Opportunities and Forecast to 2026 | Top Key Players – CareCloud Corporation , McKesson Corporation , Quest Diagnostics, The SSI Group | 10/4/2019

Revenue Cycle Management can be defined as the management of all administrative and clinical functions that directly or indirectly contribute to the revenues through patient service to optimize overall profits. Revenue cycle management undergoes various … the Revenue Cycle Management Market are: CareCloud Corporation , McKesson Corporation , Quest Diagnostics, The SSI Group, Kareo, Cerner Corporation , Allscripts , NextGen Healthcare Information Solution, eClinicalWorks , Epic Systems Corporation Get sample copy of “Revenue Cycle Management Market …

United States Medical Billing Outsourcing Market: Size, Share & Trends Analysis Report (2019-2026) - ResearchAndMarkets.com | Business Wire | 9/4/2019

Revenue Cycle Management (RCM) in various healthcare facilities varies with application. Scheduling, coding, billing, patient registration, and claims processing are adopted more than other RCM applications in the U.S. Some of the key players in this market are Allscripts; Accretive Health, Inc.; Cerner Corporation; Experian Information Solutions, Inc.; EClinicalWorks; GE Healthcare; Genpact; McKesson Corporation; Kareo; Quest Diagnostics; and The SSI Group. Further key findings from the study suggest: Advantages associated …

HIPAA

2019 health care data breaches setting records | 9/26/2019

… breaches involving more than 500 records each were reported to HHS this past July, according to a report published in HIPAA Journal . The article also said that more than 35 million individuals are known to … impacting up to 7.7 million patients. Two days before that, Quest Diagnostics experienced a similar breach with American Medical Collection Agency, potentially impacting 11.9 million patients. A record-breaking 50 health care data breaches involving …

Medicaid

ViewRay Announces Appointment of Dr. Gail Wilensky to its Board of Directors | Business & Finance | heraldchronicle.com | PR Newswire | 7/16/2019

Medicaid programs. Gail was also the first chair of the Medicare Payment Advisory Commission. Dr. Wilensky serves as a director for Quest Diagnostics, United Health Group, the Geisinger Health System Foundation, and is on the Board of Regents of the Uniformed Services University of the Health Sciences (USUHS). She is an elected member of the National Academy of Medicine and has served two terms on its governing council. Dr. Wilensky …

First Edition: June 4, 2019 | Kaiser Health News | 6/4/2019

… as well as going up with a statewide digital buy in the Bluegrass State. (Carney, 6/3) The Hill: Democrats Make Medicaid Center Of Kentucky Governor Fight Kentucky Democrats want to make the state’s 2019 gubernatorial … planned no further comment. (Wilde Mathews, 6/3) The Washington Post: Quest Diagnostics Discloses Breach Of 11.9 Million Patient Records Quest Diagnostics, the medical testing company, said a data breach has affected about 11.9 million patients …

LabCorp

Phishing scam at Presbyterian exposes 183K patients’ data | Healthcare Dive | 8/27/2019

Quest Diagnostics, LabCorp and other healthcare companies. More than 20 million records were exposed in the attack. Presbyterian is offering credit monitoring and identity protection services to patients whose Social Security numbers were exposed. It also is adding new security capabilities to its email system and requiring all employees to complete annual training on protecting information. In the case of Massachusetts General Hospital, the data exposed varied, depending on the …

Sonoma Valley Hospital Website, Email Addresses Hijacked | HealthIT Security | 8/22/2019

Quest Diagnostics, LabCorp , BioReference , Inform Diagnostics, and a host of others. AMCA notified IRL of the breach on June 3 and confirmed IRL patient data was breached on June 13. The compromised data included information from patients or those financially responsible for their care, such as names, contact details, amounts owed to IRL, dates of service, and patient account numbers. A small number of debit or credit cards were breached …

American Medical Collection Agency

July-reported healthcare breaches exposed 22 million people’s data | Modern Healthcare | 8/9/2019

American Medical Collection Agency, which has sparked a set of investigations and inquiries since it was first publicly disclosed in June. LabCorp and Quest Diagnostics in June said a data breach resulting from an unauthorized user accessing the vendor’s web payment system between August 2018 and March 2019 had affected millions of their patients, but that AMCA had not yet provided them with information on which patients’ data was exposed …

Inform Diagnostics, CompuNet Latest AMCA Data Breach Victims | HealthIT Security | 8/8/2019

American Medical Collection Agency. Nearly two months ago, Quest Diagnostics , LabCorp , and BioReference reported their patient data was breached during a hack on their billing services vendor. The unauthorized access went on for nearly eight months between August 1, 2018 and March 30, 2019—- 10 days after the breach was discovered. The notices appeared in Securities Exchange Commission 8-K filings, with officials explaining that the actual scope of the …

Optum

July-reported healthcare breaches exposed 22 million people’s data | Modern Healthcare | 8/9/2019

Quest Diagnostics in June said a data breach resulting from an unauthorized user accessing the vendor’s web payment system between August 2018 and March 2019 had affected millions of their patients, but that AMCA had not yet provided them with information on which patients’ data was exposed. After further investigation, Optum360, one of Quest’s revenue-cycle contractors, on July 1 filed a formal report of the data breach with the …

Global Computer Assisted Coding Market Analysis, Trends, and Forecasts 2019-2025 | Markets Insider | Business Insider | 7/31/2019

Optum, Inc. ( USA ) Quest Diagnostics, Inc. ( USA ) TruCode LLC. ( USA ) For more information about this report visit https://www.researchandmarkets.com/r/cjwwo0 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside …

Thermo Fisher

Genetic Testing Market 2019 Size, Share, Growth Statistics, Upcoming Trends, Comphrensive Research, analysed By Market Research Future, Forecast to 2024 | 10/1/2019

Quest Diagnostics Incorporated (US), Eurofins Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Blueprint Genetics (Finland), BGI Genomics (China), and Thermo Fisher Scientific Inc. (US). Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2009 Market Insights: Genetic testing is also known as DNA testing. Genetic tests involve a set of lab tests for the study of the genetic makeup of patients and identify any gene mutations and alterations in the …

$69.2 Bn In-Vitro Diagnostic Tests Markets, 2024 | PR Newswire | 9/25/2019

Quest Diagnostics Quidel Corporation Radiometer A/S / Danaher RainDance Technologies, Inc. Randox Laboratories Ltd. Rheonix, Inc. Roche Diagnostics Rubicon Genomics, Inc. Samsung Healthcare Scienion AG Seegene, Inc. Sekisui Diagnostics LLC Shimadzu Scientific Instruments Siemens Healthineers (Siemens) Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.) Sysmex Corporation Takara Bio Inc. Tecan Group Thermo Fisher Scientific Inc. Tosoh Bioscience Trinity Biotech Plc Trovagene, Inc. Vela Diagnostics Ventana Medical Systems Inc …

UnitedHealth

Bright Near-Term Outlook for Medical Info Systems Industry - August 27, 2019 - Zacks.com | 8/27/2019

Quest Diagnostics ( DGX - Free Report ) and UnitedHealth Group’s ( UNH - Free Report ) Optum and UnitedHealthcare formed an alliance to launch Synaptic Health Alliance pilot project on the blockchain technology. Aetna, a CVS Health business, and Ascension have also joined this program. Another new trend is the blockchain technology, a new method of storing the same amount of digital information in such a way that it takes up less space. Notably, blockchain …

Chris Davis Buys 3 Stocks in 2nd Quarter | Yahoo News | 8/14/2019

Quest Diagnostics Inc. (NYSE:DGX) and UnitedHealth Group Inc. (NYSE:UNH), among others. The guru’s $20.22 billion equity portfolio, which is composed of 132 stocks, is heavily invested in the financial services sector. cafdf256761d290d5d7c3f027e024b6b.png …

Optum360

July-reported healthcare breaches exposed 22 million people’s data | Modern Healthcare | 8/9/2019

Quest Diagnostics in June said a data breach resulting from an unauthorized user accessing the vendor’s web payment system between August 2018 and March 2019 had affected millions of their patients, but that AMCA had not yet provided them with information on which patients’ data was exposed. After further investigation, Optum360, one of Quest’s revenue-cycle contractors, on July 1 filed a formal report of the data breach with the …

More Medical Mega-Breaches Thanks To Third-Party Insecurity | Forbes | 6/14/2019

… do too. Which was on display yet again with the most recent mega-breach of the week. Medical testing giants Quest Diagnostics and LabCorp announced, via filings with the Securities and Exchange Commission (SEC), that … vendor, Optum 360. “AMCA has not yet provided Quest or Optum360 detailed or complete information about the AMCA data security incident, including which information of which individuals may have been affected. And Quest has not …

Siemens

$69.2 Bn In-Vitro Diagnostic Tests Markets, 2024 | PR Newswire | 9/25/2019

… Inc. Epigenomics AG ERBA Diagnostics, Inc. Eurobio Scientific EUROIMMUN AG Exosome Diagnostics, Inc. FABPulous B.V. Fast Track Diagnostics (acquired by Siemens Healthineers) Fio Corporation Fluidigm Corporation Focus Diagnostics, Inc. Foundation Medicine, Inc. Fujirebio Diagnostics, Inc … QIAGEN N.V. Q-linea AB QuanDx Inc QuantuMDx Group, Ltd. Quest Diagnostics Quidel Corporation Radiometer A/S / Danaher RainDance Technologies, Inc. Randox Laboratories Ltd. Rheonix, Inc. Roche Diagnostics Rubicon Genomics, Inc. Samsung Healthcare Scienion AG …

Colorectal Cancer Market is Growing Due to Targeted Therapy Followed by Immunotherapy and Chemotherapy | Reports and Data | 9/24/2019

Quest Diagnostics, Sanofi SA, Siemens Healthineers and VolitionRX, among others. The key geographical regions mapped here are North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. This document gives a competitive analysis of the individual standing of the companies against the global landscape. The forecast also provides the estimated trends in demand for the market and their impact on the sizes of these companies to help the reader …

GE Healthcare

Europe Revenue Cycle Management (RCM) Market Insight, Secondary Research With Prime Players Like Kareo, Cerner Corporation, GE Healthcare, Epic, Quest Diagnostics, athenahealth, Siemens Healthineers, McKesson | 9/9/2019

… Change Healthcare announced that it has been selected by LabPharm Hospital Management Services (HMS) (U.S.). Their RCM services supported national network of hospitals and independent laboratories. Get ToC Of Full Report: https://databridgemarketresearch.com/toc/?dbmr=europe-revenue-cycle-management-market Product Launch In June 2018, Quest Diagnostics, the world’s leading provider of diagnostic information services, unveiled the newest version of its Quanum Enterprise Content Management Solution. This latest release of …

United States Medical Billing Outsourcing Market: Size, Share & Trends Analysis Report (2019-2026) - ResearchAndMarkets.com | Business Wire | 9/4/2019

GE Healthcare; Genpact; McKesson Corporation; Kareo; Quest Diagnostics; and The SSI Group. Further key findings from the study suggest: Advantages associated with outsourcing of medical billing services include improvement in billing process by decreasing errors, swift turnaround time, and smooth administrations for hospitals and other medical institutes Outsourced medical billing is likely to witness the highest growth during the forecast period owing to growing focus on minimizing the cost of …

Abbott Laboratories

Genetic Testing Market 2019 Size, Share, Growth Statistics, Upcoming Trends, Comphrensive Research, analysed By Market Research Future, Forecast to 2024 | 10/1/2019

Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Illumina Inc. (US), Myriad Genetics, Inc. (US), PerkinElmer Inc. (US), QIAGEN N. V. (Germany), Quest Diagnostics Incorporated (US), Eurofins Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Blueprint Genetics (Finland), BGI Genomics (China), and Thermo Fisher Scientific Inc. (US). Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2009 Market Insights: Genetic testing is also known as DNA testing. Genetic tests involve a …

Global Cervical Cancer Diagnostic Tests Market Analysis, Growth, Size, Share, Study, Demand & Forecast 2019-2026: Abbott Laboratories, BD Medical, Roche Molecular Diagnostics | 9/25/2019

Global Cervical Cancer Diagnostic Tests Market Analysis, Growth, Size, Share, Study, Demand & Forecast 2019-2026: Abbott Laboratories, BD Medical, Roche Molecular Diagnostics 4 mins ago Ann.Castro The “ Cervical Cancer Diagnostic Tests Market “ report is a profound … players Abbott Laboratories, BD Medical, Roche Molecular Diagnostics, Hologic, Qiagen, Quest Diagnostics, BioMerieux, Cepheid, Arbor Vita, Trovagene, DAAN Gene, Delphi Bioscience, Fujirebio Diagnostics in the Cervical Cancer Diagnostic Tests market. Click here to access the …

Opko Health

32M patient records breached in 2019. That’s double all of 2018, Protenus reports | FierceHealthcare | 8/7/2019

Quest Diagnostics, LabCorp, Opko Health, under one of its subsidiaries, BioReference Laboratories, Inc., and Clinical Pathology Laboratories. It’s estimated that the number of patients’ data potentially exposed by the breach is now over 22 million. The incident was discovered when patient data was found for sale on the Dark Web. Hacking was the cause of 60% of the total number of breaches throughout the first half of the year, affecting …

Morgan Stanley

Quest Diagnostics (NYSE:DGX) Upgraded at Zacks Investment Research - TheOlympiaReport | 9/30/2019

Quest Diagnostics (NYSE:DGX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. The firm presently has a $111.00 target price on … has been the topic of a number of other reports. Morgan Stanley upped their price target on Quest Diagnostics from $111.00 to $121.00 and gave the stock an “overweight” rating in a research report on …

Quest Diagnostics Inc (NYSE:DGX) Receives $105.00 Consensus PT from Analysts | 9/2/2019

Shares of Quest Diagnostics Inc (NYSE:DGX) have been given an average recommendation of “Hold” by the twenty brokerages that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a … 90.00 to $85.00 in a report on Monday, July 15th. Morgan Stanley increased their price target on shares of Quest Diagnostics from $111.00 to $121.00 and gave the stock an “overweight” rating in a report …

Goldman Sachs

Quest Diagnostics Inc (NYSE:DGX) Short Interest Update | 9/30/2019

Quest Diagnostics Inc (NYSE:DGX) was the target of a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 3,610,000 shares, a drop of 7.9 … a “neutral” rating in a report on Wednesday, July 24th. Goldman Sachs Group downgraded Quest Diagnostics from a “neutral” rating to a “sell” rating and cut their price target for the stock from $90.00 to …

Brokerages Set Quest Diagnostics Inc (NYSE:DGX) Target Price at $105.00 | 9/25/2019

Shares of Quest Diagnostics Inc (NYSE:DGX) have been given a consensus rating of “Hold” by the twenty ratings firms that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the … of equities research analysts recently issued reports on DGX shares. Goldman Sachs Group lowered shares of Quest Diagnostics from a “neutral” rating to a “sell” rating and dropped their price objective for the company from …

Jefferies Financial Group

Q3 2019 Earnings Forecast for Quest Diagnostics Inc Issued By Jefferies Financial Group (NYSE:DGX) | 8/17/2019

Quest Diagnostics Inc (NYSE:DGX) – Equities researchers at Jefferies Financial Group lowered their Q3 2019 EPS estimates for Quest Diagnostics in a research note issued to investors on Wednesday, July 24th, according to Zacks Investment Research . Jefferies Financial Group analyst B. Tanquilut now expects that the medical research company will earn $1.72 per share for the quarter, down from their previous estimate of $1.74. Get Quest Diagnostics alerts: Quest Diagnostics

Q3 2019 EPS Estimates for Quest Diagnostics Inc (NYSE:DGX) Reduced by Analyst | 8/17/2019

Quest Diagnostics Inc (NYSE:DGX) – Equities research analysts at Jefferies Financial Group decreased their Q3 2019 EPS estimates for shares of Quest Diagnostics in a research note issued on Wednesday, July 24th, Zacks Investment Research reports. Jefferies Financial Group analyst B. Tanquilut now forecasts that the medical research company will post earnings per share of $1.72 for the quarter, down from their prior forecast of $1.74. Get Quest Diagnostics alerts …

SunTrust Bank

CENTRAL TRUST Co Boosts Stock Holdings in Quest Diagnostics Inc (NYSE:DGX) | 8/21/2019

CENTRAL TRUST Co Boosts Stock Holdings in Quest Diagnostics Inc (NYSE:DGX) Posted by William Eddington on Aug 20th, 2019 Tweet CENTRAL TRUST Co grew its stake in Quest Diagnostics Inc (NYSE:DGX) by 11.2 … after purchasing an additional 225,712 shares in the last quarter. Suntrust Banks Inc. grew its position in shares of Quest Diagnostics by 11.7% during the fourth quarter. Suntrust Banks Inc. now owns 4,337 shares of …

Gateway Investment Advisers LLC Lowers Stake in Quest Diagnostics Inc (NYSE:DGX) | 8/21/2019

Gateway Investment Advisers LLC lessened its stake in Quest Diagnostics Inc (NYSE:DGX) by 0.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 114,421 shares of the … 178,437,000 after purchasing an additional 225,712 shares during the period. Suntrust Banks Inc. increased its position in shares of Quest Diagnostics by 11.7% in the fourth quarter. Suntrust Banks Inc. now owns 4,337 shares of …

William Blair

William Blair Comments on Quest Diagnostics Inc’s FY2019 Earnings (NYSE:DGX) | 8/18/2019

Quest Diagnostics Inc (NYSE:DGX) – Equities researchers at William Blair upped their FY2019 earnings per share estimates for shares of Quest Diagnostics in a research report issued on Tuesday, July 23rd, Zacks Investment Research reports. William Blair analyst M. Larew now forecasts that the medical research company will earn $6.52 per share for the year, up from their prior estimate of $6.45. William Blair also issued estimates for Quest Diagnostics

Quest Diagnostics Inc (NYSE:DGX) Expected to Earn Q3 2020 Earnings of $1.76 Per Share | 8/12/2019

Quest Diagnostics Inc (NYSE:DGX) Expected to Earn Q3 2020 Earnings of $1.76 Per Share Posted by Frank Smitson on Aug 12th, 2019 Quest Diagnostics Inc (NYSE:DGX) – William Blair lowered their Q3 2020 earnings per share estimates for Quest Diagnostics in a research report issued on Tuesday, July 23rd, according to Zacks Investment Research . William Blair analyst M. Larew now forecasts that the medical research company will post earnings …

BlackRock Inc.

Quest Diagnostics Inc (NYSE:DGX) Shares Acquired by Vanguard Group Inc. | 9/22/2019

Vanguard Group Inc. raised its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 0.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC … after purchasing an additional 818,490 shares in the last quarter. BlackRock Inc. grew its position in shares of Quest Diagnostics by 4.2% in the first quarter. BlackRock Inc. now owns 13,551,752 shares of the medical …

IFG Advisory LLC Has $430,000 Position in Quest Diagnostics Inc (NYSE:DGX) | 9/17/2019

IFG Advisory LLC lifted its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 2.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor … have also recently bought and sold shares of the company. BlackRock Inc. raised its stake in shares of Quest Diagnostics by 4.2% in the first quarter. BlackRock Inc. now owns 13,551,752 shares of the medical …

BlackRock

Quarterly Review Of DivGro: Q2 2019 | Seeking Alpha | 7/22/2019

… Blackrock ( BLK ) — income of $115.50 Chubb ( CB ) — income of $36.50 Comcast ( CMCSA ) — income of $42.00 Cummins ( CMI ) — income of $57.00 Cisco Systems ( CSCO ) — income of $35.00 CVS Health ( CVS ) — income of $100.00 Chevron ( CVX ) — income of $28.56 Dominion Energy ( D ) — income of $91.75 Quest Diagnostics ( DGX ) — income of $106.00 Digital Realty Trust ( DLR ) — income of $48.60 Ford Motor ( F ) — income of $300.00 FedEx ( FDX ) — income of $9.75 Federal Realty Income …

Norinchukin Bank The Has $2.38 Million Stake in Quest Diagnostics Inc (DGX) | 6/4/2019

Norinchukin Bank The Has $2.38 Million Stake in Quest Diagnostics Inc (DGX) Posted by Wayne Landers on Jun 4th, 2019 // Comments off Norinchukin Bank The lifted its stake in shares of Quest Diagnostics Inc (NYSE … after buying an additional 201,951 shares in the last quarter. BlackRock Inc. grew its position in shares of Quest Diagnostics by 4.2% during the first quarter. BlackRock Inc. now owns 13,551,752 shares of the medical …

Wellington Management

Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management | PR Newswire | 7/12/2019

ATLANTA , July 12, Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX ) have formed a collaboration designed to improve digital health and disease management … technology investment firms such as Claritas Capital; noted crossover fund Wellington Management; Wells Fargo; and Swiss Re, one of the world’s largest reinsurance providers. Since its founding, Sharecare has raised in excess of $400 million …

Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management | Markets Insider | Business Insider | 7/12/2019

… July 12, 2019 /PRNewswire/ – Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease … technology investment firms such as Claritas Capital; noted crossover fund Wellington Management; Wells Fargo; and Swiss Re, one of the world’s largest reinsurance providers. Since its founding, Sharecare has raised in excess of $400 million …

GE Ventures

DIGITAL HEALTH BRIEFING: UnitedHealth Group creates $250 million venture fund — EKG band approved for Apple Watch — New study shows Google is effective transcription tool | Business Insider | 12/1/2017

… benefit of reducing the time doctors spend documenting visits — 1.5 hours on an average day, according to Google’s study. NEW GE VENTURES COMPANY CUTS MIDDLEMAN OUT OF BLOOD DRAWS: Drawbridge Health , a startup backed by … cut out blood-draw facilities operated by lab companies like Quest Diagnostics — which brought in $7.5 billion in revenue in 2016. For patients in remote areas especially, this can eliminate one of the main barriers …

GE Ventures unveils new blood collection startup Drawbridge Health | TechCrunch | 11/29/2017

GE Ventures unveils new blood collection startup Drawbridge Health Posted Chinese electric vehicle maker NIO more concerned with user experience than rival Tesla Drawbridge Health wants to make it easier for doctor’s offices and clinics … normally have to get done at an outside lab like Quest Diagnostics or Lab Corp. Instead, the device can stay in the clinic and the proprietary Drawbridge cartridge holding your blood would be shipped out …

Merrill Lynch

Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 7/24/2019

Quest Diagnostics Incorporated (NYSE: DGX ) Q2 2019 Results Conference Call July 23, 2019 8:30 AM ET Company Participants Shawn Bevec - VP, IR Steve Rusckowski - Chairman, CEO and President Mark Guinan - CFO Conference Call Participants Ralph … Bill Quirk - Piper Jaffray Derik de Bruin - Bank of America Merrill Lynch Matt Larew - William Blair Eric Coldwell - Baird Mark Massaro - Canaccord Genuity Operator Welcome to the Quest Diagnostics Second Quarter 2019 Conference Call. At …

Quest Diagnostics’ (DGX) CEO Steve Rusckowski on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 4/23/2019

Quest Diagnostics Incorporated (NYSE: DGX ) Q1 2019 Earnings Conference Call April 23, 2019 8:30 AM ET Company Participants Shawn Bevec – Vice President-Investor Relations Steve Rusckowski – Chairman, President and Chief Executive Officer Mark Guinan – Chief … Jefferies Erin Wright – Credit Suisse Ivy Ma – Bank of America Merrill Lynch Bill Quirk – Piper Jaffray Stephen Baxter – Wolfe Research Lisa Gill – JPMorgan Matt Larew – William Blair Mark Massaro – Canaccord Genuity Eric Coldwell – Baird Operator …

HCA

Exclusive: Philips, under investigation in U.S. and Brazil, fired whistleblower who warned of graft | Yahoo News | 8/21/2019

Healthcare giant Philips was warned of suspicious sales of its medical equipment to the Brazilian government, and failed to halt them, nearly a decade before an alleged bribery racket was exposed in the company’s Brazil … for comment. He is now CEO of New Jersey-based Quest Diagnostics DGX.N . In an emailed statement to Reuters, Philips said it is cooperating with Brazilian authorities investigating the nation’s medical device industry. The company …

Cleveland Clinic, Cleveland OH

Quest Diagnostics stock price target raised to $105 from $96 at J.P. Morgan | MarketWatch | 12/19/2017

… Services Market is Expected to Exceed US$ 17.50 Billion by 2021 Dec. 14, 2017 at 3:43 a.m. ET on Financeswire Quest Diagnostics Completes Acquisition of Shiel Medical Laboratory from Fresenius Medical Care Dec. 12, 2017 … Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland Clinic Dec. 1, 2017 at 1:00 p.m. ET on PR Newswire - PRF The Global Computer-assisted Coding Market Is Projected To Reach USD 4.75 …

Quest Diagnostics Agrees To Acquire Cleveland HeartLab | Seeking Alpha | 10/25/2017

Quest Diagnostics Agrees To Acquire Cleveland HeartLab Oct.25.17 Quest Diagnostics will acquire Cleveland HeartLab for an undisclosed sum. The HeartLab is a pioneer in alternative biomarker testing for cardiovascular disease. Quest is acquiring the … 13 billion market capitalization. The HeartLab was created by the Cleveland Clinic, which intends to collaborate with Quest to ‘accelerate the conversion of emerging innovations into diagnostic services,’ and on trials that aim to more …

Cleveland Clinic

Quest Diagnostics stock price target raised to $105 from $96 at J.P. Morgan | MarketWatch | 12/19/2017

… Services Market is Expected to Exceed US$ 17.50 Billion by 2021 Dec. 14, 2017 at 3:43 a.m. ET on Financeswire Quest Diagnostics Completes Acquisition of Shiel Medical Laboratory from Fresenius Medical Care Dec. 12, 2017 … Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland Clinic Dec. 1, 2017 at 1:00 p.m. ET on PR Newswire - PRF The Global Computer-assisted Coding Market Is Projected To Reach USD 4.75 …

Quest Diagnostics Agrees To Acquire Cleveland HeartLab | Seeking Alpha | 10/25/2017

Quest Diagnostics Agrees To Acquire Cleveland HeartLab Oct.25.17 Quest Diagnostics will acquire Cleveland HeartLab for an undisclosed sum. The HeartLab is a pioneer in alternative biomarker testing for cardiovascular disease. Quest is acquiring the … 13 billion market capitalization. The HeartLab was created by the Cleveland Clinic, which intends to collaborate with Quest to ‘accelerate the conversion of emerging innovations into diagnostic services,’ and on trials that aim to more …

Cape Cod Healthcare

Quest Diagnostics to Buy MedXM, Boost Home Health Services | Zacks | 1/26/2018

Quest Diagnostics to Buy MedXM, Boost Home Health Services Zacks Equity Research Trades from $ 3 Read More Hide Full Article Quest Diagnostics ( DGX - Free Report ) recently announced a definitive agreement to buy a leading national … and plans to acquire the outreach laboratory services business of Cape Cod Healthcare buoy optimism. We are also upbeat about Quest Diagnostics and Clinical Genomics, a major player in the field of colorectal cancer detection …

Quest Diagnostics to Buy MedXM, Boost Home Health Services - January 26, 2018 - Zacks.com | 1/26/2018

Quest Diagnostics ( DGX - Free Report ) recently announced a definitive agreement to buy a leading national provider of home-based health risk assessments and related services — Mobile Medical Examination Service (MedXM). The financial terms of the … and plans to acquire the outreach laboratory services business of Cape Cod Healthcare buoy optimism. We are also upbeat about Quest Diagnostics and Clinical Genomics, a major player in the field of colorectal cancer detection …

Hartford HealthCare

Quest Diagnostics to Buy MedXM, Boost Home Health Services | Zacks | 1/26/2018

Quest Diagnostics to Buy MedXM, Boost Home Health Services Zacks Equity Research Trades from $ 3 Read More Hide Full Article Quest Diagnostics ( DGX - Free Report ) recently announced a definitive agreement to buy a leading national … company’s completion of thebuyout of outreach laboratory service operations of Hartford HealthCare hospitals — The William W. Backus Hospital and The Hospital of Central Connecticut. The company has also completed the acquisition of Med Fusion and …

Quest Diagnostics to Buy MedXM, Boost Home Health Services - January 26, 2018 - Zacks.com | 1/26/2018

Quest Diagnostics ( DGX - Free Report ) recently announced a definitive agreement to buy a leading national provider of home-based health risk assessments and related services — Mobile Medical Examination Service (MedXM). The financial terms of the … company’s completion of thebuyout of outreach laboratory service operations of Hartford HealthCare hospitals — The William W. Backus Hospital and The Hospital of Central Connecticut. The company has also completed the acquisition of Med Fusion and …

St. Joseph Health

Premier Inc. Recognizes Hospitals, Health Systems and Suppliers for Improving Healthcare Quality and Costs | Business Wire | 6/21/2019

… Foundation Hospital, Illinois, The Carle Foundation Catawba Valley Medical Center, North Carolina Central Texas Medical Center, Texas of AdventHealth CHI St. Joseph Health Regional Hospital, Texas of CHI Texas Division Clifton Springs Hospital & Clinic, New … Hillrom Kimberly-Clark Professional Merck & Co., Inc. PNC Bank, N.A. Quest Diagnostics Ruiz Food Products, Inc. Siemens Healthineers STERIS Corporation Xerox Corporation Supplier Horizon Award The following suppliers received the Horizon Award for exceptional local …

Quest Diagnostics Acquires California Laboratory Associates | PR Newswire | 10/30/2017

Quest Diagnostics Acquires California Laboratory Associates Transaction Expands Access to Innovative, High-Value Diagnostic Information Services in Southern California News provided by 06:45 SECAUCUS, N.J. and BURBANK, Calif. Quest Diagnostics (NYSE: DGX), the world’s leading … quality laboratory services,” said Erik G. Wexler , Chief Executive, Providence St. Joseph Health, Southern California Region. “We are confident Quest Diagnostics will carry on the high standards our caregivers set in providing quality and compassionate …

PeaceHealth

Premier Inc. Recognizes Hospitals, Health Systems and Suppliers for Improving Healthcare Quality and Costs | Business Wire | 6/21/2019

… new practice’s effectiveness and potential applicability to other healthcare settings. This year’s award winners are: Eisenhower Health, Rancho Mirage, California PeaceHealth, Vancouver, Washington Texas Health Harris Methodist Hospital Fort Worth, Arlington, Texas Culinary Cup Award … Hillrom Kimberly-Clark Professional Merck & Co., Inc. PNC Bank, N.A. Quest Diagnostics Ruiz Food Products, Inc. Siemens Healthineers STERIS Corporation Xerox Corporation Supplier Horizon Award The following suppliers received the Horizon Award for exceptional local …

Quest Diagnostics Buys Fresenius Medical’s Shiel Laboratory - December 13, 2017 - Zacks.com | 12/13/2017

Quest Diagnostics ( DGX - Free Report ) recently completed the buyout of Shiel Medical Laboratory from Fresenius Medical Care AG & Co. KGaA ( FMS - Free Report ) — a healthcare company working on renal and other chronic conditions. The Shiel … The company is particularly positive about its recent agreement with PeaceHealth in the Pacific Northwest, which is expected to driive growth in 2017. Also, management is optimistic about the latest acquisitions of Med Fusion and …

Providence St. Joseph Health

Quest Diagnostics Acquires California Laboratory Associates | PR Newswire | 10/30/2017

Quest Diagnostics Acquires California Laboratory Associates Transaction Expands Access to Innovative, High-Value Diagnostic Information Services in Southern California News provided by 06:45 SECAUCUS, N.J. and BURBANK, Calif. Quest Diagnostics (NYSE: DGX), the world’s leading … ensure quality laboratory services,” said Erik G. Wexler , Chief Executive, Providence St. Joseph Health, Southern California Region. “We are confident Quest Diagnostics will carry on the high standards our caregivers set in providing quality and …

AHN

QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX | Business Wire | 7/20/2019

NEW ORLEANS- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Quest Diagnostics Incorporated (NYSE: DGX). On June 3, 2019, the Company disclosed that it had been notified by a billing services vendor that, between August 1, 2018 and March 30, 2019, an unauthorized user had gained access to …

Geisinger Health System

ViewRay Announces Appointment of Dr. Gail Wilensky to its Board of Directors | Business & Finance | heraldchronicle.com | PR Newswire | 7/16/2019

Quest Diagnostics, United Health Group, the Geisinger Health System Foundation, and is on the Board of Regents of the Uniformed Services University of the Health Sciences (USUHS). She is an elected member of the National Academy of Medicine and has served two terms on its governing council. Dr. Wilensky was a former chair of the board of directors of Academy Health and a trustee of the American Heart Association. She …

Global Specimen Validity Test (SVT) Reagents Market 2017-2025: Market was valued at US$ 832.8 Mn in 2016, and is expected to reach US$ 1,341.9 Mn by 2025 - Research and Markets | Business Wire | 11/30/2017

Geisinger Health System HireRight, LLC LabCorp (Laboratory Corporation of America) Mayo Medical Laboratories Options Lab, Inc. Quest Diagnostics, Inc. Redwood Toxicology Laboratory SciTest Laboratories, Inc. For //www.researchandmarkets.com/research/l7hvsx/global_specimen In Vitro Diagnostics …

UnitedHealthcare

Quest Diagnostics (DGX) Q2 Earnings, Revenues Beat Estimates | Zacks | 7/23/2019

We are upbeat about Quest Diagnostics’ expanded network access which has helped the company accelerate volume growth in the second quarter. This strong volume growth combined with its strategy to attain operational excellence has helped the company counter significant reimbursement pressure. The new Preferred Lab Network status within UnitedHealthcare, which represents a multi-year opportunity, buoys optimism. However, declining revenue per requisition and contraction in operating margin were disappointing. Zacks …

What You Need to Know About Quest Diagnostics' Q2 Earnings Results | Yahoo News | 7/23/2019

What You Need to Know About Quest Diagnostics’ Q2 Earnings Results Keith Speights, The Motley Fool Reblog The last time Quest Diagnostics (NYSE: DGX) announced its quarterly results , in April, revenue increased 0.4% compared to … Diagnostics gained Preferred Lab Network status with UnitedHealth Group ‘s UnitedHealthcare segment during the second quarter. Rusckowski stated that this will be a multiyear opportunity for the company that will develop over time. The company …

Aetna

Bright Near-Term Outlook for Medical Info Systems Industry - August 27, 2019 - Zacks.com | 8/27/2019

Quest Diagnostics ( DGX - Free Report ) and UnitedHealth Group’s ( UNH - Free Report ) Optum and UnitedHealthcare formed an alliance to launch Synaptic Health Alliance pilot project on the blockchain technology. Aetna, a CVS Health business, and Ascension have also joined this program. Another new trend is the blockchain technology, a new method of storing the same amount of digital information in such a way that it takes up less space. Notably, blockchain …

How blockchain has strange bedfellows singing kumbaya | Managed Care Magazine | 7/5/2019

Aetna; Ascension, the largest Catholic health care system in the country; MultiPlan benefit administrators; Cognizant professional services; and Quest Diagnostics. Other blockchain alliances include: IBM health utility network, which preceded Synaptic’s launch announcement by two months, is composed of Cigna, Aetna (again), Health Care Service Corporation (HCSC), and Anthem, along with Sentara Healthcare and PNC Bank. Coalesce Health Alliance comprises Express Scripts, the Blue Cross Blue Shield plans in Massachusetts …

Humana

Bright Near-Term Outlook for Medical Info Systems Industry - August 27, 2019 - Zacks.com | 8/27/2019

Humana ( HUM - Free Report ) , MultiPlan, Quest Diagnostics ( DGX - Free Report ) and UnitedHealth Group’s ( UNH - Free Report ) Optum and UnitedHealthcare formed an alliance to launch Synaptic Health Alliance pilot project on the blockchain technology. Aetna, a CVS Health business, and Ascension have also joined this program. Another new trend is the blockchain technology, a new method of storing the same amount of digital information in such a way that it takes …

Chris Davis Buys 3 Stocks in 2nd Quarter | Yahoo News | 8/14/2019

… be purchased at value prices, preferably when they are out of favor. Based on these criteria, Davis established holdings in Humana Inc. (NYSE:HUM), China Index Holdings Ltd. (NASDAQ:CIH) and Welltower Inc. (NYSE:WELL … Education & Technology Group Inc. (NYSE:EDU), Encana Corp. (NYSE:ECA), Quest Diagnostics Inc. (NYSE:DGX) and UnitedHealth Group Inc. (NYSE:UNH), among others. The guru’s $20.22 billion equity portfolio, which is composed of 132 stocks …

CareCentrix

Compromise by Proxy? Why You Should Be Losing Sleep Tonight | Inc.com | ZDNet | 6/20/2019

Quest Diagnostics, LabCorp, BioReference Laboratories, Carecentrix, and Sunrise Laboratories. The companies used AMCA as their customer bill payment portal. During the eight months the vulnerability was unaddressed by AMCA, hackers had access to the company’s online payment page, and with that a cornucopia of sensitive personally identifiable information that included financial data, Social Security numbers, and, in one case, medical information. Lamentable, Avoidable, Illegal and Expensive This epic cybersecurity fail …

Data breach forces medical debt collector AMCA to file for bankruptcy protection | ZDNet | 6/19/2019

Quest Diagnostics, LabCorp, BioReference Laboratories, Carecentrix, and Sunrise Laboratories. Security Cyberwar and the future of cybersecurity (free PDF download) The companies in question used AMCA’s payment portal to bill their medical customers. At least 20 million US citizens have been impacted by the security incident, in which the hacker responsible ransacked AMCA’s internal systems to pillage user data including names, Social Security numbers, addresses, dates of birth, and payment card …

Horizon Blue Cross Blue Shield Of New Jersey

Here’s Why You Should Invest in Quest Diagnostics (DGX) Stock - Nasdaq.com | 6/6/2019

Shutterstock photo Quest Diagnostics, Inc . DGX is progressing well with its two-point strategy that focuses on restoring growth and driving operational excellence. In the past three months, the company’s shares have outperformed the industry … the Midwest. Banking on its in-network status with UnitedHealthcare, Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of Georgia, the company has already added 43 million customers. This represents …

MultiPlan

How blockchain has strange bedfellows singing kumbaya | Managed Care Magazine | 7/5/2019

MultiPlan benefit administrators; Cognizant professional services; and Quest Diagnostics. Other blockchain alliances include: IBM health utility network, which preceded Synaptic’s launch announcement by two months, is composed of Cigna, Aetna (again), Health Care Service Corporation (HCSC), and Anthem, along with Sentara Healthcare and PNC Bank. Coalesce Health Alliance comprises Express Scripts, the Blue Cross Blue Shield plans in Massachusetts and Michigan, HealthNow New York, Horizon Healthcare Services of New Jersey …

Existing and Emerging Technologies to Advance Value-Based Care | HealthPayer Intelligence | 6/17/2019

… promising future for value-based care technology The majority of providers and health plans from an annual survey conducted by Quest Diagnostics agree that certain technologies have the greatest potential to improve the effectiveness of … and transparency in healthcare. More than a year ago, Humana, MultiPlan, Optum, Quest Diagnostics, and UnitedHealthcare unveiled a cooperative blockchain pilot program to improve data quality and reduce administrative costs around provider data management. Healthcare …

Steve Rusckowski

Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference | PR Newswire | 8/23/2019

SECAUCUS, N.J. , Aug. 23, Quest Diagnostics Incorporated (NYSE: DGX ), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Baird 2019 Global Healthcare Conference in New York. Steve Rusckowski , Chairman, President and CEO and Jim Davis , Executive Vice President, General Diagnostics will discuss the company’s vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for …

Exclusive: Philips, under investigation in U.S. and Brazil, fired whistleblower who warned of graft | Yahoo News | 8/21/2019

… after with the company’s top compliance officer, and alerted at least three other senior executives during 2010. Among them was Steve Rusckowski, former chief executive of Philips Healthcare, the company’s largest division. Masiero’s warnings were … for comment. He is now CEO of New Jersey-based Quest Diagnostics DGX.N . In an emailed statement to Reuters, Philips said it is cooperating with Brazilian authorities investigating the nation’s medical device industry. The company …

Cory Booker

Data breaches in 2019 already double all of last year | Healthcare Dive | 8/2/2019

… the year stemmed from a hack of American Medical Collection Agency , a major collections agency working for companies such as Quest Diagnostics and LabCorp. More than 20 million patient records were breached, with hackers gaining … into the issue, with two U.S. senators (including presidential hopeful Cory Booker, D-N.J.) sending a letter to New Jersey-based Quest inquiring into the cause of the breach, and how it went unnoticed. The …

AMCA Files Chapter 11 After Data Breach Impacting Quest, LabCorp | HealthIT Security | 6/18/2019

… 11 After Data Breach Impacting Quest, LabCorp After an eight-month data breach impacted up to 20 million patients of Quest Diagnostics, LabCorp, and BioReference, AMCA has filed for Chapter 11 protection – aiming to liquidate … followed suit, as Democratic New jersey Sens. Bob Menendez and Cory Booker sent letters to all three vendors demanding officials explain how a hack could go undetected for eight months and other breach details. The …

Bob Menendez

AMCA Files Chapter 11 After Data Breach Impacting Quest, LabCorp | HealthIT Security | 6/18/2019

… 11 After Data Breach Impacting Quest, LabCorp After an eight-month data breach impacted up to 20 million patients of Quest Diagnostics, LabCorp, and BioReference, AMCA has filed for Chapter 11 protection – aiming to liquidate … investigation. Other states followed suit, as Democratic New jersey Sens. Bob Menendez and Cory Booker sent letters to all three vendors demanding officials explain how a hack could go undetected for eight months and other …

AMCA data breach has now went over the 20 million mark | ZDNet | 6/15/2019

… now also started notifying their own customers of their billing partner’s security snafu. The list of impacted testing laboratories includes Quest Diagnostics (11.9 million patients), LabCorp (7.7 million patients), BioReference Laboratories (Opko Health subsidiary, 422,600 … has to pass. Democratic New Jersey Sens. Cory Booker and Bob Menendez also sent letters to AMCA, Quest, and LabCorp , seeking official answers on how a breach of this severity went undetected for eight months …

Mark Warner

AMCA data breach has now went over the 20 million mark | ZDNet | 6/15/2019

… now also started notifying their own customers of their billing partner’s security snafu. The list of impacted testing laboratories includes Quest Diagnostics (11.9 million patients), LabCorp (7.7 million patients), BioReference Laboratories (Opko Health subsidiary, 422,600 … being the first to do so . In Washington, US Sen. Mark Warner (D-VA) also sent a letter to Quest Laboratories demanding the company explain its vetting process for selecting AMCA as a billing vendor …

AMCA data breach has now gone over the 20 million mark | ZDNet | 6/15/2019

… now also started notifying their own customers of their billing partner’s security snafu. The list of impacted testing laboratories includes Quest Diagnostics (11.9 million patients), LabCorp (7.7 million patients), BioReference Laboratories (Opko Health subsidiary, 422,600 … being the first to do so . In Washington, US Sen. Mark Warner (D-VA) also sent a letter to Quest Laboratories demanding the company explain its vetting process for selecting AMCA as a billing vendor …

Boh Hatter

It’s Never 2 Late Renews Sage Growth Partners as Agency of Record | PR Newswire | 9/30/2019

… technology companies have the wealth of success stories that iN2L has – a library that grows with testimonials every day,” said Boh Hatter , SGP CMO and General Manager, Marketing. “It’s striking to hear how iN2L’s solutions … in Baltimore, MD and serves clients such as Philips Healthcare, Quest Diagnostics, Inspirata, Livongo, Ingenious Med, and North Jersey Brain and Spine. Visit us online at www.sage-growth.com . Media Contact Vanessa Ulrich (410) 534.1161 vulrich …

Signallamp Retains Sage Growth Partners for Strategic Marketing Communications Services | PR Newswire | 6/20/2019

… point in its growth and needs to capitalize on the track record of success and trustworthiness it has built,” said Boh Hatter , SGP CMO and General Manager, Marketing. “Signallamp is well positioned to capitalize on … in Baltimore, MD and serves clients such as Philips Healthcare, Quest Diagnostics, Launchpoint, Ingenious Med, and ArborMetrix. Visit us online at www.sage-growth.com . Media Contact Vanessa Ulrich (410) 534.1161 [email protected] SOURCE Sage Growth …

Jeff Arnold

Remark Holdings Comments on Investment in Sharecare Led by Quest Diagnostics | Markets Insider | Business Insider | 7/15/2019

LAS VEGAS , July 15, 2019 /PRNewswire/ – Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence (AI) solutions and digital media properties, today commented on the recently announced strategic investment in Sharecare led by Quest Diagnostics. “We are proud to have been a founding technology partner of Sharecare, supporting Jeff Arnold , Dr. Oz and the team they have assembled in building Sharecare, whose recent round of …

Mackenzie Garrity

AMCA files for bankruptcy after massive data breach | Becker’s Hospital Review | 6/19/2019

AMCA files for bankruptcy after massive data breach Mackenzie Garrity - Print Email After disclosing a March data breach that exposed millions of patients’ health information, the American Medical Collection Agency has filed for Chapter 11 … exposed the personal health information of millions, many belonging to Quest Diagnostics and LabCorp. Combined, Quest and LabCorp alerted close to 20 million patients that their information may have been affected. Since the data breach …

Quest Diagnostics hit with class-action lawsuit following 11.9 million-patient data breach - Becker’s Hospital Review | 6/13/2019

Quest Diagnostics hit with class-action lawsuit following 11.9 million-patient data breach Mackenzie Garrity - Print Email Florida law firm Morgan & Morgan filed a class-action lawsuit on June 12 in New Jersey against Quest Diagnostics after the laboratory testing company disclosed that it had experienced a data breach that exposed 11.9 million patients, according to the Connecticut Law Tribune . Attorneys general in Connecticut and Illinois have also opened investigations …

John Cunningham

WORLD AIDS DAY 2017 | PR Newswire | 12/1/2017

… a boulder in honor of President Bill Clinton during World AIDS Day observances in San Francisco. Pictured with the President John Cunningham, Executive Director. (Photo Credit: Trish Tunney) President Bill Clinton pays tribute to those … Senior Vice President, R&D, Medical and Chief Medical Officer, Quest Diagnostics. “Quest Diagnostics is honored to support the National AIDS Memorial and its mission to honor the lives lost to AIDS and help ensure …

Kai-Shing Tao

Remark Holdings Reports Second Quarter 2019 Results | PR Newswire | 8/9/2019

… in the real estate, pharmacy, and transportation sectors, while working with additional partners to expand upon our retail deployments,” said Kai-Shing Tao , Chairman and Chief Executive Officer of Remark Holdings. “Our focus on our … than $10 million . Sharecare received a strategic investment led by Quest Diagnostics, further highlighting the value Sharecare is creating. Remark owns approximately five percent of Sharecare’s issued stock and continues to explore avenues to optimize …

Remark Holdings Reports Second Quarter 2019 Results | Markets Insider | Business Insider | 8/8/2019

… in the real estate, pharmacy, and transportation sectors, while working with additional partners to expand upon our retail deployments,” said Kai-Shing Tao , Chairman and Chief Executive Officer of Remark Holdings. “Our focus on our … than $10 million . Sharecare received a strategic investment led by Quest Diagnostics, further highlighting the value Sharecare is creating. Remark owns approximately five percent of Sharecare’s issued stock and continues to explore avenues to optimize …

Bob Beechey

Austin cancer-fighting company shuffles a pair of C-suite financial execs | The Business Journals | 12/21/2017

… Inc., an Austin company that develops cancer diagnostic tests for women, has shuffled the financial roles in its C-suite. Bob Beechey has been hired as chief financial officer, succeeding Eric Schoen , the company’s senior … Solutions, a clinical trials laboratory joint venture between IQvia and Quest Diagnostics . Regulatory filings show Beechey will receive an annual base salary of $280,000 and will be eligible for an annual performance bonus worth up …

Vermillion Appoints Bob Beechey to Newly Created CFO Post | PR Newswire | 12/19/2017

… 2017 /PRNewswire/ – Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced it has appointed Bob Beechey CPA to the newly created post of Chief Financial Officer. “We are very … Solutions, a clinical trials laboratory joint venture between IQvia and Quest Diagnostics. Prior to the formation of the Q Squared Solutions joint venture, Mr. Beechey served as Quintiles Transnational’s Vice President of Internal Audit and …